FilingsAtlas Logo - Company Search & Market Tools
FilingsAtlas

Cardlytics, Inc. (CDLX) Financial Statements

Industry: Computer Programming, Data Processing, Etc. (Services)

In fiscal 2025, Cardlytics reported revenue of $233.3M, down 16.2% from $278.3M the year before. Net income was -$103.5M (a -44.4% net margin), or -$19.50 per diluted share. Gross margin was -43.6% and operating margin was -43.6%. Operating activities generated $9.3M of cash, leaving $8.8M of free cash flow. At fiscal year end, Cardlytics held $285.6M in total assets against $292.1M in total liabilities, including $48.7M of cash and equivalents.

Open the full interactive Cardlytics financials → Quarterly statements, key ratios, valuation history and price charts.

Cardlytics Key Stats

Share Price$2.16
Market Cap$12.4M
Revenue YoY Growth-16.2%
52-Week Range$1.95 – $21.50
Shares Outstanding5.8 million (basic, 2026 Q2)

Cardlytics Income Statement

Cardlytics, Inc. annual income statement
FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$186.9M$267.1M$298.5M$309.2M$278.3M$233.3M
Cost of Goods Sold$240.8M$389.7M$756.3M$444.9M$473.8M$335.1M
Gross Profit-$53.9M-$122.6M-$457.8M-$135.7M-$195.5M-$101.8M
Operating Income-$53.9M-$122.6M-$457.8M-$135.7M-$195.5M-$101.8M
Pre-Tax Income-$55.4M-$136.4M-$466.7M-$134.7M-$189.3M-$103.5M
Income Tax$0$7.9M-$1.4M$0$0$0
Net Income-$55.4M-$128.6M-$465.3M-$134.7M-$189.3M-$103.5M
Diluted EPS-$20.40-$39.90——-$39.10-$19.50

Cardlytics Quarterly Results

Cardlytics, Inc. last 4 quarters
2025 Q32025 Q42026 Q12026 Q2
Revenue$52.0M$56.1M$34.3M$36.9M
Net Income-$72.7M-$8.2M-$4.5M-$14.9M
Diluted EPS-$13.60-$0.16-$0.82-$2.58

Cardlytics Balance Sheet

Cardlytics, Inc. annual balance sheet (fiscal year end)
FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash & Equivalents$293.2M$233.5M$121.9M$91.8M$65.6M$48.7M
Current Assets$385.6M$358.7M$250.0M$223.9M$178.0M$137.3M
Total Assets$422.5M$1.26B$691.2M$574.1M$392.7M$285.6M
Current Liabilities$81.3M$327.4M$248.9M$171.1M$149.0M$78.4M
Total Long-Term Debt$174.0M$184.4M$226.0M$257.5M$218.6M$212.6M
Total Liabilities$265.3M$573.1M$479.6M$439.3M$322.7M$292.1M
Shareholders' Equity$157.2M$690.7M$211.6M$134.8M$70.0M-$6.5M

Cardlytics Cash Flow Statement

Cardlytics, Inc. annual cash flow statement
FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash From Operations-$7.6M-$38.5M-$53.9M-$185,000-$8.8M$9.3M
Cash From Investing-$10.1M-$506.7M-$15.8M-$10.1M-$18.7M-$15.3M
Cash From Financing$206.4M$486.0M-$40.0M-$20.0M$1.4M-$11.1M
Free Cash Flow-$13.0M-$41.6M-$55.1M-$852,000-$10.4M$8.8M

Figures from Cardlytics' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Cardlytics financials page for every line item.

Cardlytics Company Profile

TickerCDLX
ExchangeNasdaq
IndustryComputer Programming, Data Processing, Etc. (Services)
HeadquartersAtlanta, Georgia
Incorporated inDelaware
Fiscal Year EndDecember 31
SEC Filer CategoryAccelerated filer, smaller reporting company
SEC CIK0001666071

Frequently Asked Questions

What was Cardlytics' revenue in fiscal 2025?

Cardlytics (CDLX) reported revenue of $233.3M for fiscal 2025.

What is Cardlytics' annual revenue history?

Cardlytics' annual revenue by fiscal year: 2020: $186.9M; 2021: $267.1M; 2022: $298.5M; 2023: $309.2M; 2024: $278.3M; 2025: $233.3M.

What was Cardlytics' net income in fiscal 2025?

Cardlytics reported net income of -$103.5M for fiscal 2025.

What was Cardlytics' earnings per share (EPS) in fiscal 2025?

Cardlytics' diluted EPS was -$19.50 for fiscal 2025 (adjusted for any later stock splits).

How much free cash flow did Cardlytics generate in fiscal 2025?

Cardlytics generated $8.8M of free cash flow in fiscal 2025.

What was Cardlytics' revenue last quarter?

In its most recent reported quarter (2026 Q2), Cardlytics reported revenue of $36.9M.

How much debt does Cardlytics have?

Cardlytics reported $212.6M of long-term debt, including the current portion, at the end of fiscal 2025.

How many shares of Cardlytics are outstanding?

Cardlytics reported a weighted average of 5.8 million basic shares outstanding in 2026 Q2.

What is Cardlytics' market cap?

Based on its latest closing price, Cardlytics (CDLX) has a market capitalization of about $12.4M.

When does Cardlytics' fiscal year end?

Cardlytics' fiscal year end, as registered with the SEC, is December 31.

Where is Cardlytics headquartered?

Cardlytics lists its business address in Atlanta, Georgia in its SEC filings.